Remicade and Brain death - a phase IV clinical study of FDA data
Summary:
Brain death is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Prednisolone, and have Colitis.
The study is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.
What is Remicade?
Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.
222,651 people reported to have side effects when taking Remicade.
Among them, 17 people (0.01%) died.

Among these 17 people:
How long have people been on Remicade when they died? *
- < 1 month: 40 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 40 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 20 %
- 10+ years: 0.0 %
What is the gender of people who died when taking Remicade? *
- female: 58.82 %
- male: 41.18 %
What is the age of people who died when taking Remicade? *
- 0-1: 7.69 %
- 2-9: 15.38 %
- 10-19: 7.69 %
- 20-29: 7.69 %
- 30-39: 7.69 %
- 40-49: 46.15 %
- 50-59: 0.0 %
- 60+: 7.69 %
What are other drugs people take besides Remicade? *
- Prednisolone: 5 people, 29.41%
- Methotrexate: 4 people, 23.53%
- Benadryl: 4 people, 23.53%
- Gravol: 4 people, 23.53%
- Solu-Cortef: 3 people, 17.65%
- Tylenol: 2 people, 11.76%
- Etidronate Disodium: 2 people, 11.76%
- Folic Acid: 2 people, 11.76%
- M.v.i.: 1 person, 5.88%
- Cyclosporine: 1 person, 5.88%
What are other side effects people have before they died? *
- Breathing - Slowed Or Stopped: 7 people, 41.18%
- Cerebral Infarction (less blood supply to brain resulting tissue damage): 5 people, 29.41%
- Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 4 people, 23.53%
- Loss Of Consciousness: 4 people, 23.53%
- Fall: 4 people, 23.53%
- Cerebral Oedema (swelling of brain): 3 people, 17.65%
- Beta Haemolytic Streptococcal Infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue): 3 people, 17.65%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 17.65%
- Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 3 people, 17.65%
- Muscle Cramps (painful sensations caused by muscle contraction): 2 people, 11.76%
What are the existing conditions these people have? *
- Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 5.88%
- Colitis (inflammation of colon): 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Remicade:
- Remicade (224,011 reports)
Expand to all the drugs that have ingredients of infliximab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Remicade:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Brain death:
- Brain death (317 drugs)
Browse all the conditions that are associated with Brain death:
- Brain death (489 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ventavis cause Depressed Level Of Consciousness? - 10 seconds ago
- Could Proair Hfa cause Muscle Atrophy? - 29 seconds ago
- Could Azopt cause Musculoskeletal Chest Pain? - 54 seconds ago
- Could Pomalyst cause Urticaria? - a minute ago
- Could Aldactone cause Seizures? - a minute ago
- Could Exemestane cause Deep Venous Thrombosis? - 2 minutes ago
- Could Cannabis cause Chest Pain? - 2 minutes ago
- Could Lidocaine Hydrochloride cause Crohn'S Disease? - 2 minutes ago
- Could Acetaminophen cause Drug-Induced Liver Injury? - 3 minutes ago
- Drug interactions of Celexa and Heparin - 3 minutes ago